{micro}-Theraphotoxin-Pn3a inhibition of Cav3.3 channels reveals a novel isoform-selective drug binding site
J. R. McArthur, J. Wen, A. Hung…·D. J. Adams
This study identifies Pn3a as a subtype-selective inhibitor of CaV3.3 T-type calcium channels, revealing a novel isoform-specific binding site with therapeutic potential.